Beijing Tiantan Biological Products Corp Ltd (600161) — Net Asset Momentum
Beijing Tiantan Biological Products Corp Ltd (600161) recorded a net asset momentum of 13.9% as of December 2024, with net assets of CN¥14.53 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check 600161 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Beijing Tiantan Biological Products Corp Ltd Net Asset Momentum (1995–2024)
This chart tracks Beijing Tiantan Biological Products Corp Ltd's year-over-year net asset growth across 30 annual reporting periods from 1995 to 2024. The most recent momentum reading is +13.9%, with net assets of CN¥14.53 Billion CNY as of December 2024. Read 600161 liabilities breakdown for a breakdown of total debt and financial obligations.
Annual Net Asset History for Beijing Tiantan Biological Products Corp Ltd (1995–2024)
The table below shows the complete annual net asset history for Beijing Tiantan Biological Products Corp Ltd from 1995 to 2024, covering 30 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is Beijing Tiantan Biological Products Corp worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥14.53 Billion | CN¥15.87 Billion | CN¥1.34 Billion | ▲ +13.9% |
| 2023 | CN¥12.75 Billion | CN¥14.19 Billion | CN¥1.43 Billion | ▲ +12.3% |
| 2022 | CN¥11.36 Billion | CN¥12.94 Billion | CN¥1.58 Billion | ▲ +10.6% |
| 2021 | CN¥10.27 Billion | CN¥11.58 Billion | CN¥1.31 Billion | ▲ +70.2% |
| 2020 | CN¥6.03 Billion | CN¥7.54 Billion | CN¥1.51 Billion | ▲ +16.5% |
| 2019 | CN¥5.18 Billion | CN¥6.31 Billion | CN¥1.14 Billion | ▲ +19.1% |
| 2018 | CN¥4.35 Billion | CN¥5.07 Billion | CN¥720.19 Million | ▲ +36.5% |
| 2017 | CN¥3.18 Billion | CN¥3.67 Billion | CN¥481.46 Million | ▲ +30.5% |
| 2016 | CN¥2.44 Billion | CN¥5.78 Billion | CN¥3.34 Billion | ▲ +9.2% |
| 2015 | CN¥2.24 Billion | CN¥5.63 Billion | CN¥3.40 Billion | ▲ +0.8% |
| 2014 | CN¥2.22 Billion | CN¥6.02 Billion | CN¥3.80 Billion | ▲ +1.9% |
| 2013 | CN¥2.18 Billion | CN¥5.63 Billion | CN¥3.46 Billion | ▲ +22.5% |
| 2012 | CN¥1.78 Billion | CN¥4.81 Billion | CN¥3.03 Billion | ▲ +22.9% |
| 2011 | CN¥1.45 Billion | CN¥3.22 Billion | CN¥1.78 Billion | ▲ +26.6% |
| 2010 | CN¥1.14 Billion | CN¥2.45 Billion | CN¥1.31 Billion | ▲ +20.3% |
| 2009 | CN¥949.13 Million | CN¥2.16 Billion | CN¥1.21 Billion | ▲ +25.4% |
| 2008 | CN¥756.97 Million | CN¥1.20 Billion | CN¥439.35 Million | ▲ +4.3% |
| 2007 | CN¥725.57 Million | CN¥1.09 Billion | CN¥369.34 Million | ▲ +2.4% |
| 2006 | CN¥708.35 Million | CN¥1.06 Billion | CN¥356.20 Million | ▲ +5.9% |
| 2005 | CN¥669.09 Million | CN¥848.76 Million | CN¥179.67 Million | ▲ +5.1% |
| 2004 | CN¥636.79 Million | CN¥762.49 Million | CN¥125.70 Million | ▲ +6.2% |
| 2003 | CN¥599.70 Million | CN¥758.95 Million | CN¥159.24 Million | ▲ +107.5% |
| 2002 | CN¥289.04 Million | CN¥504.77 Million | CN¥215.73 Million | ▼ -0.2% |
| 2001 | CN¥289.68 Million | CN¥463.32 Million | CN¥173.64 Million | ▲ +3.8% |
| 2000 | CN¥279.21 Million | CN¥445.98 Million | CN¥166.77 Million | ▼ -0.2% |
| 1999 | CN¥279.67 Million | CN¥439.55 Million | CN¥159.88 Million | ▲ +5.2% |
| 1998 | CN¥265.80 Million | CN¥378.34 Million | CN¥112.54 Million | ▲ +187.8% |
| 1997 | CN¥92.37 Million | CN¥157.25 Million | CN¥64.88 Million | ▲ +53.5% |
| 1996 | CN¥60.19 Million | CN¥133.25 Million | CN¥73.06 Million | ▲ +0.9% |
| 1995 | CN¥59.67 Million | CN¥124.85 Million | CN¥65.18 Million | — |